Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Viatris Pharmaceuticals Co., Ltd.

Clinical trials sponsored by Viatris Pharmaceuticals Co., Ltd., explained in plain language.

Now part of Viatris Inc. VTRS NASDAQ

Global healthcare company focused on generic and branded medicines.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New lupus drug candidate cenerimod tested in chinese patients

Disease control Ongoing

This phase 2 trial is testing an experimental drug called cenerimod in 15 Chinese adults with moderate-to-severe systemic lupus erythematosus (SLE). Participants take a 4 mg tablet daily for 12 months while continuing their usual lupus medications. The study focuses on safety, ho…

Phase: PHASE2 • Sponsor: Viatris Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC